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Abstract 
Introduction. Malaria in pregnancy is associated with high incidences of maternal and neonatal mortality in malaria 
endemic regions. World Health Organization recommends Intermittent Presumptive treatment of malaria in 
pregnancy with Sulfadoxine-Pyrimethamine (IPTp-SP). It is recommended that every pregnant woman receives at 
least three doses administered one month apart up to the time of delivery. Despite increased antenatal clinic 
attendance and concerted efforts to address known barriers to uptake of malaria preventive measures in Navakholo 
Sub-County, uptake of three or more IPTp-SP doses in the Sub-County has remained low. 
Objective. This study aimed at determining predictors of optimum uptake of intermittent presumptive treatment of 
malaria in pregnancy among women in Navakholo Sub-County.  
Methodology. This was a cross sectional study using mixed methods of data collection. The study was carried out 
in Navakholo Sub-County, Kakamega County, Kenya. Multistage cluster sampling method was employed to attain 
sample size (n = 608). Data was analyzed using descriptive statistics, bivariate and multivariate logistic regression 
while thematic analysis was used for qualitative data. Strength of association between independent variables and 
dependent variables was measured using odd ratio and p ≤ 0.05 used to reject null hypothesis of no association 
between independent variables and the main outcome which was the uptake of optimum doses of IPTp-SP.  
Results. Out of the 587 participants, 294(50.1%) took optimum doses (three or more doses) of IPTp-SP, 248(42.2%) 
took IPTp-SP partially (one-two doses) and 45 (7.7%) did not take any dose.  The following variables were 
statistically significantly associated with uptake of optimum doses of IPTp-SP: having attained secondary level of 
education and above (OR = 0.6, 95% CI 0.4-0.98, p = 0.01); distance to health facility (OR = 0.2, 95% CI 0.06-
0.8, p = 0.02); perception that SP drugs are not safe during pregnancy (OR = 7.3, 95% CI 1.5-35.7, p = < 0.01); 
opening of health facilities daily (OR = 161.8, 95% CI 29.5-885.7 p < 0.0001) and giving clients return dates (OR 
= 21.2, 95% CI 7.9-56.5, p = < 0 .0001).  
Conclusion: Key factors that determine optimum uptake of IPTp-SP in the study area are: having attained at least 
secondary level of education; perceived safety of SP drugs; distance to health facility; opening of health facility 
daily and giving of return dates to clients.  
Recommendation: - Community awareness through health education to increase awareness on the risks of malaria 
in pregnancy and safety of SPs in pregnancy.  The study further recommends that the daily opening of facilities 
within the study area, ensure return dates are given at every visit and introduction of mobile clinics to those who 
are staying far away from the nearest health facility. 
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1.0 Introduction  
Malaria in pregnancy (MiP) contributes significantly to global maternal mortality in Sub-Saharan Africa. In 2015, 
malaria was the third most common cause of mortality among women of reproductive age in Africa. Malaria was 
estimated to have been responsible for more than 400,000 cases of maternal anemia and approximately 15% of 
maternal deaths globally. Unfortunately, the women who are most vulnerable to malaria are often the least 
protected against it. MiP also poses a significant threat to newborns because it can cause spontaneous abortion, 
stillbirth, premature delivery, low birth weight and neonatal mortality (Malaria Health Task Force, 2018). 
A lot of efforts have been put in place to try and eradicate malaria infection. One of the aims of Roll Back 
Malaria (RBM) program that was adopted following the Abuja Declaration in 2000, was to ensure that by 2010, 
80% of pregnant women would be protected from malaria. It was also anticipated that universal coverage would 
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have been achieved by 2015 through prophylaxis with Sulfadoxine 500mg - Pyrimethamine 25mg (SP) and Long-
Lasting Insecticidal Nets (LLINs) as key interventions (Gifty, 2010; Akoria, 2014). IPTp-SP is often associated 
with several benefits, among which are reduction in the risk of maternal anaemia and improvement of the outcomes 
of the fetus and neonatal life (WHO, 2012).  
Several factors have been associated with uptake of IPTp-SP. In a study carried out in Tanzania, uptake of 
IPTp-SP was low due to uncertainty expressed by pregnant women on the safety of SP drugs in pregnancy. Uptake 
of IPTp-SP was further worsened when given to be swallowed at home (Kibusi, 2015). Similar findings were 
reported by Mbonye et al., (2006) who found that expectant mothers in Uganda were concerned with side effects 
anti-malarial drugs pose to themselves and their unborn babies. In addition, study findings from National Malaria 
Control Program (2014), identified client’s socio-demographic factors such as age, marital status, level of 
education, parity, religion, occupational status and residence playing a major role in determining the uptake of 
IPTp-SP among pregnant women. 
Kibusi, (2015) reported that among the gravid women at risk of missing IPTp-SP were young women aged 
15-19 years as they were found to be starting their ANC visits late and hence low uptake of IPTp-SP. Higher 
uptake was associated with those in age bracket of 30-39 years. In Burkina Faso, Gies (2009) noted that ANC 
attendance increased with increase in age. A study conducted by Mutulei, (2013) found out that 82.2% of women 
in Bungoma, Kenya who had accessed two or more doses of IPTp-SP were married.  In a related study carried out 
in Malawi, it was noted that the motivating factors for taking IPTp-SP included support from husbands, the desire 
to protect their children and themselves from malaria infection and the related complications (Mpanga et al., 2014).  
According to Mwandama et al., (2013), higher level of education is associated with the uptake of two or more 
doses of IPTp-SP. In a study that was done in Kenya, uptake of IPTp-SP was significantly associated with a 
woman’s educational status (Mutulei, 2013). Similarly, other studies have reported that low levels of IPTp-SP 
uptake were associated with low levels of education (Agaba, 2013; Kibusi 2015). Employment also influenced 
optimum uptake of IPTp-SP as was found out in a study conducted in Korle-Bu Teaching Hospital in Accra 
(Ghana). The findings revealed that most of the women (80%) not using IPTp-SP were of low income compared 
with 62.9% of those using (De Allegri et al., 2011). A study conducted in Juba, Southern Sudan, reported 
significant association between income and uptake of both ITN and IPTp-SP (Napoleon et al., 2011). Uptake of 
IPTp-SP was more likely among respondents with lower income than those with higher income. A woman’s parity 
was equally found to be associated with optimum uptake of IPTp-SP. In a study where 142 women of different 
parities of between para1+0 and para 4+0 were interviewed, uptake of IPTp-SP was significantly associated with 
multiparity (Mutulei, 2013). Multiparous women tend to meet the focused antenatal care (FANC) requirements of 
at least attaining 4 visits before delivery time. According to Iliyasu (2012), most of the pregnant women in Urban 
Kano in Northern Nigeria who were para two and above started their ANC visits in the 2nd trimester (14-24 weeks’ 
gestation) unlike the primigravidae who commonly started in their 3rd trimester (28-32 weeks’ gestation) who did 
not manage to attain the required number of minimum of 4 visits.  In a study that was done in Bungoma, where 
most of the respondents (75%) were Christians and Muslims (15%), it revealed that the uptake of IPTp-SP and 
religious affiliation were not significantly associated (Mutulei, 2013). Despite high antenatal clinic attendance and 
increased efforts to address known barriers to the uptake of malaria preventive measures in the study area, uptake 
of 3 or more IPTp-SP doses in Navakholo Sub-County has remained low. The current uptake of IPTp-SP doses in 
the Sub-County is 40% short of the national target of 80% (DHIS2, 2017; NMS, 2009-2017) and slightly above 
that of the entire Kakamega county that stands at 20% (KDHS, 2014).  Therefore, to scale up the uptake of IPTp-
SP, there is need to determine the predictors of optimum uptake of IPTp-SP in the study area.  
 
2.0 Methodology 
2.1 Study Design 
This was a cross sectional analytical study design using mixed methods for data collection.  
 
2.2 Study setting 
The study was carried out in Navakholo Sub-County (see Appendix V). The main ethnic groups residing in this 
area are the Banyala and Batsotso whose dialects are Kinyala and Kitsotso respectively. The Sub-County falls 
within the malaria-endemic zone on the eco-epidemiological map of Kenya and malaria risk class of 20% or more 
(Mutulei, 2013). Health facilities in the Sub-County includes Navakholo Sub-County Hospital, three public health 
centres (Kharanda, Sivilie and Bushiri) and eight government dispensaries (Namirama, Buchangu, Sisokhe, 
Budonga, Butingo, Eshihongo, Ematiha and Kisembe). The Sub-County has two Faith Based health facilities, 
namely: Lutaso and Ingotse Dispensaries both of which offer ANC services including administration of Directly 
Observed Therapy (DOT) of IPTp-SP (DHIS- Navakholo Sub-County unpublished report, 2016). There are 13 
community health units where Community Health Volunteers (CHV) through community health strategy enhances 
access to health care under the supervision of a Community Health Extension Worker (CHEW). Each CHV visits 
households assigned to them once every month where they provide pregnant women with haematenics, dewormers 
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and health education. They also advise on immunization of their children and refer pregnant mothers to the health 
care facilities whenever they feel it is necessary, basically monitoring the health of the household members.  
 
2.3 Study population 
The study population comprised of women who had delivered within the last twelve months, and hence were 
expected to have sought ANC services, including IPTp-SP within the study area during the study period.  
 
2.4 Sampling technique 
Multistage sampling method was used. Stage one involved listing of the wards and random selection of three wards 
out of the five was done. In the second stage, three Sub-Locations were randomly selected out of the eight. Finally, 
households with post-delivery women were listed from each of the villages in the three sub-locations. Simple 
random sampling was used to select the 608 respondents based on the sampling frame which was compiled for 
each village. The 3 health facilities where Key Informant Interviews (KII) were done were purposively selected 
based on the maternal health services they offered. The facilities included one sub-county hospital, one public 
health centre and one faith-based dispensary. Four Focus Group Discussions (FGDs) of between 6-7 individuals 
per group were conducted one in each of the wards except for Bunyala West where 2 FGDs were done because of 
its relatively larger population of 38,407 (1 at Sidikho Chief’s camp and 1 at Lusumu primary school}, the rest 
was one in each ward, i.e. 1 at Namirama Friend’s Church in Bunyala East ward, and 1 at Nambacha Market in 
Bunyala Central Ward.  
 
2.5 Eligibility criteria 
2.5.1 Inclusion criteria 
Women who had delivered within the preceding twelve months and resident of Navakholo for the past six months 
or more before the study. 
2.5.2 Exclusion Criteria 
Women on Co-trimoxazole prophylaxis, those with history of allergy to sulfa drugs and non-residents.  
 
2.6 Sample Size 
The researcher used the “Modified EPI” Formula to estimate the minimum sample size. 
n= D*Z2*pq/e2 
Where n = sample size, D = Design factor (1.5), Z = confidence interval (1.96), p = proportion of those taking 
optimum IPTp - SP doses (40%), q = proportion of those not taking optimum doses of IPTp-SP (60%) and e = 
margin of error (0.05). The researcher added 10% of the sample size to cater for non-response. With these 
parameters, the computation yielded a sample size of 608 women. 
 
2.7 Research Instruments 
For quantitative data collection, the researcher modified and adopted a questionnaire that was used by Atasige, et 
al., (2016) and Ameh et al., (2016) in two studies conducted in a rural northern Ghana-Gushegu District and Cross 
River State in Nigeria, respectively.  
2.7.1 Quantitative data collection tool 
The researcher used a structured questionnaire which was divided into the following three sections: Section 1. 
Client characteristics; Section 2. Health facility related factors; and Section 3. Health provider related factors. The 
questionnaire was in English language and translated into Kiswahili in order to ease its execution and standardize 
responses. The questionnaire was again back-translated into English to ensure correct translation and no loss of 
meaning for each question. The questionnaire was evaluated to increase its validity and reliability. The instrument 
was pre-tested in Lurambi Sub-county which was outside the study area. The reliability of the instrument was 
relatively high (Cronbach’s α = 0.7). 
2.7.2 Qualitative data collection tool 
Qualitative data was collected using focus group discussion (FGD) and key informant interview (KII). A total of 
four FGDs were conducted in each Ward with each group having 6-7 participants who delivered within the last 12 
months. The FGD interview guide questions focused on knowledge, attitude and practice on IPTp-SP. For KII, 
their interview guide included questions on health provider and health facility related factors that influence 
optimum uptake of IPTp-SP doses. KII targeted the in-charges of MCH/FP departments in three health facilities, 
one in each ward.  
 
2.8 Data Collection Procedures  
The researcher conducted a three-days training for 7 research assistants (RAs) who were engaged in collection of 
quantitative data from the participants. The training focused on how to identify eligible respondents, interview 
techniques and ethical issues. The RAs comprised of 2 Kenya Registered Community Health Nurses (KRCHN), 
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1 Nutritionist, 3 Community Health Volunteers CHVs) and 1 Supply Chain Management Officer (SCMO). 
Qualitative data was collected by the Principle Researcher. Data collection was undertaken from October to 
November 2017. 
 
2.9 Data Analysis. 
Quantitative data were entered, coded, cleaned and analyzed using Statistical Package for Social Sciences (SPSS) 
software version 22. Proportions were calculated using total number of respondents and denominator calculated 
based on the total number of respondents. Differences in the proportions were determined by calculating the 
confidence interval and the summary chi square statistic using Mantel Haenszel stratified cross-tabulations. p-
values of ≤ 0.05 were regarded as statistically significant. Differences in the associations between categorical 
variables were assessed using Logistic Regression analysis. The Logistic Regression model was fitted to compare 
the association of optimum uptake of IPTp-SP and client characteristics (demographic and socio-economic factors), 
as well as health provider and health facility factors. The dependent variable was optimum uptake of IPTp-SP 
(three or more doses).  
 
2.10 Ethical considerations 
Approval to carry out the study was obtained from Institutional Ethics Review Committee (IERC) of Masinde 
Muliro University of Science and Technology. Further permission was sort from the County Administration. 
Authority to conduct the survey was granted by the National Commission for Science Technology and Innovation 
(NACOSTI).  
Before commencing data collection, in order to introduce the project and answer any questions and concerns 
requiring clarifications, the researcher conducted an information session with service providers and community 
gate keepers. During interviews, study participants were taken through general questions about uptake of IPTp-SP 
with a view of identifying factors associated with optimum uptake of SP for prevention of malaria during 
pregnancy. These questions did not pose any risks to the participants. 
Research assistants were especially cognizant of the importance of informing respondents at the various sites 
about the study and the purpose of the research and assuring them that their information would be kept confidential 
and anonymous. The researcher ensured that oral and written consent were obtained from the respondents before 
being interviewed. Participants were assured of confidentiality and that their participation was voluntary and that 
they were free to opt out at any stage without loss of any benefits. Therefore, all interviews were conducted within 
the respondent’s home and in a private area but respecting the cultural norms. If the respondent indicated that she 
was uncomfortable holding the interview at that point, the interview was then shifted at another location of the 
interviewee’s preference and convenience. 
 
3.0 Results 
3.1 Background characteristics of the respondents.  
A total of 608 women participated in the study. Twenty-one (3.5%) of the questionnaires that were incomplete due 
to missing data of key variables were excluded from data analysis leaving a total of 587 questionnaires that were 
analyzed. Table 1 shows socio-demographic characteristics of the respondents who were interviewed. The mean 
age was 26.8 years with a standard deviation of 6.1 years. The age range was between 15 to 50 years. Most of the 
respondents were in the age category of 25 – 34 (47.4%) and 15 – 24 (40.6%) years, respectively. Majority (91.8%) 
were married or living with a partner. More than two-thirds (70.5%) had attained primary level of education 
compared with 25% who had completed secondary education. Most of the respondents (55%) were farmers with 
more than one-quarter (28.6%) being housewives. Nearly two-thirds (63.2%) were protestants compared to 22.8% 
who were Catholics.  
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Table 1 Background characteristics of respondents 
 
                                         
Religion 
Catholic  134 22.8 
Protestant 371 63.2 
Muslim 79 13.5 
Atheist 3 0.5 
3.1.1 Client characteristics associated with uptake of IPTp-SP  
Table 2 presents client characteristics that are associated with optimum uptake of IPTp-SP.  Women who were 
protestants were one and a half times more likely to receive optimal doses of IPTp-SP than those who belonged to 
other religious groups such as Catholics and Muslims, among others (OR: 1.6; 95% CI: 1.1 – 2.2; p = 0.01). The 
number of previous pregnancies was significantly associated with optimal uptake of IPTp-SP. Women who had 
less than 4 previous pregnancies were two-fold more likely to receive optimal doses of IPTp-SP compared with 
their counterparts who had higher number of previous pregnancies (OR: 2.0; 95% CI: 1.3 – 3.2; p = 0.002). 
Similarly, women who had less than 4 previous deliveries were about two times more likely to receive at least 
three or more doses of IPTp-SP in contrast to those who had higher number of deliveries (OR: 1.7; 95%CI: 1.1 – 
2.8; p = 0.02). Uptake was lowest among clients who had attained secondary school education and above compared 
with those who had primary or no education, although the association was marginal (OR: 0.7; 95% CI: 0.5 – 1.0; 
p = 0.06).  
  
Variable Categories N % 
Age groups (in years) 15 – 24 238 40.6 
25 – 34 278 47.4 
35 – 44 69 11.7 
≥45 2 0.3 
Mean age± SD (Range) in years 26.8±6.1 (15.0 – 50.0) 
Marital status Single 43 7.3 
Married 539 91.8 
Divorced 1 0.2 
Widow 1 0.2 
Separated 3 0.5 
Level of education None 6 1.0 
Primary 414 70.5 
Secondary 147 25.0 
Tertiary 20 3.4 
Occupation Housewife  168 28.6 
Farmer 323 55.0 
Employed 16 2.7 
Self-employed/Business  61 10.4 
Student 19 3.2 
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Table 2 Client characteristics associated with uptake of IPTp-SP 
Risk factor  
N 
Uptake of IPTp-SP Overall 
OR 
95% CI Significance 
level 
(p value) 
≥3 doses of 
IPTp-SP 
<3 doses of IPTp-SP 
Age group:       
30 – 39 years 152 55.3 44.7 1.1 0.7 – 1.5 0.7 
< 30 or >=40 years 435 53.8 46.2 
Marital status:       
Married 539 54.7 45.3 1.3 0.7 – 2.3 0.4 
Not married 48 47.9 52.1 
Level of education:       
At least secondary 
school 
165 47.9 52.1 0.7 0.5 – 1.0 0.06 
Primary school or 
none 
422 56.6 43.4 
Occupation:       
Housewife 168 50.6 49.4 0.8 0.6 – 1.2 0.2 
Employed 419 55.6 44.4 
Religion:       
Protestant 371 58.2 41.8 1.6 1.1 – 2.2 0.01 
Others 102 47.2 52.8 
Past obstetric hx:       
<4 previous 
pregnancies 
491 57.0 43.0 2.0 1.3 – 3.2 0.002 
≥4 previous 
pregnancies 
96 39.6 60.4 
Past delivery hx:       
<4 previous deliveries 502 56.2 43.8 1.7 1.1 – 2.8 0.02 
≥4 previous deliveries 85 42.4 57.6 
 
3.2 Factors associated with access to health facility and uptake of IPTp-SP 
Table 3 presents findings on access to the nearest health facility and reveals a significant relationship between 
attendance of the clinic and uptake of optimal doses of IPTp-SP. Women who perceived that distance affects clinic 
attendance were 60% less likely to receive optimal doses unlike their colleagues who thought otherwise (OR: 0.4; 
95% CI: 0.2- 0.9; p = 0.02). Women coming from areas where their nearest health facility opens every day were 
about 53 times more likely to receive optimal doses of IPTp-SP (OR: 52.8; 95% CI: 16.5 – 169.2; p < 0.0001). 
The rest of the other facility-related factors had no significant association with the outcome (optimum uptake of 
IPTp-SP). Distance was mentioned as a hindrance to attend clinic as reported during the FGD in one of the sessions: 
I stay far away from the hospital and it is not possible for me to attend clinic frequently. Client’s remark. 
This was further confirmed by a second participant during FGD: “We find it difficult to reach the clinic 
because of distance. You have to hire a motorcycle at £ 0.5 for you to reach the health facility because it is not 
good for a pregnant woman to walk long distances. A remark from a Participant in Bunyala East Ward. 
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Table 3: Factors associated with access to health facility and uptake of IPTp-SP 
Risk factor  
 
n 
Uptake of IPTp-SP Overall 
OR 
95% CI Significance 
level 
(p value) 
≥3 doses of 
IPTp-SP 
<3 doses of 
IPTp-SP 
Access to health facility hindered 
by geographical barriers: 
      
No  411 54.0 46.0 1.0 0.7 – 1.4 0.9 
Yes 176 54.6 45.6 
Type of health facility that is 
nearest: 
      
Dispensary 317 54.9 45.1 1.1 0.8 – 1.5 0.7 
Others 270 53.3 46.7 
Time taken to reach nearest health 
facility: 
      
> 1 hour 326 54.4 45.6 1.0 0.7 – 1.4 0.9 
≤ 1 hour 261 54.0 46.0 
Distance affects clinic attendance:       
Yes 545 52.8 47.2 0.4 0.2 – 0.9 0.02 
No 42 71.4 28.6 
Nearest health facility open every 
day: 
      
Yes 494 63.8 36.2 52.8 16.5 – 169.2 < 0.0001 
No 93 3.2 96.8 
 
3.3 Health provider related factors that affect uptake of optimum doses of IPTp-SP  
The relationship between provider related factors and optimal uptake of IPTp-SP was explored and presented in 
Table 4. Giving of return dates was a predictor of optimal uptake of IPTp-SP. Clients who were given return dates 
by health providers during their visits were 5-times more likely to receive the recommended optimal uptake of at 
least three doses of IPTp-SP than those who were not given return dates (OR: 4.7; 95% CI: 2.6 – 8.6; p < 0.0001).  
Table 4: Health Provider factors associated with uptake of IPTp- SP 
Risk factor  
N 
Uptake of IPTp-SP Overall 
OR 
95% 
CI 
Significance 
level (p value) ≥3 doses 
of IPTp-
SP 
<3 doses 
of IPTp-
SP 
Health education on pregnancy 
provided to you by the health 
provider during ANC visit clear and 
concise. 
      
Yes 547 54.1 45.9 1.0 0.5 – 
1.8 
0.9 
No 40 55.0 45.0 
Staff ready to answer your concerns       
Yes 549 54.5 45.5 1.2 0.6 – 
2.3 
0.6 
No 38 55.2 45.3 
Given return dates by the health 
provider during your visits: 
      
Yes 521 58.2 41.8 4.7 2.6 – 
8.6 
< 0.0001 
No 66 22.7 77.3 
Although findings from quantitative study did not find any association between issuance of ANC card and 
uptake of IPTp-SP, results from KII revealed that expectant mothers feel secure when issued with ANC cards. 
Expectant women will therefore come to collect this cards and once they have acquired them, they stay at home 
and are unlikely to receive optimal doses of IPTp-SP. Such cards help them to avoid possible confrontation with 
the midwives as is supported by the following sentiments from one of the KII respondents: 
Our clients are well informed. They know when faced with difficult labour at home, they will be brought to us. 
They know that the first thing we ask for is the ANC card. So they make sure at least they have registered and have 
a card just in case it becomes necessary. They say we quarrel them and may refuse to attend to them (Nurse at 
Sivilie Health Centre and Lutaso Dispensary giving a similar remark). 
Support supervision is a key component in management in which staffs get motivated to provide evidence 
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based healthcare. This study found out that focused supervision on IPTp-SP was lacking in the sampled health 
facilities and thus affecting optimum uptake of IPTp-SP as supported by the remarks from a facility in-charge as 
indicated below: 
We are supervised by the County and sometimes Sub-County Health Management Teams but they have never come 
here to make a follow up on the issue of IPTp-SP in particular (Remarks of a Nurse in Navakholo Sub-County 
Hospital). 
 
3.4 Predictors of optimum uptake of IPTp-SP  
A multivariate logistic regression was performed to identify predictors of the optimum uptake of IPTp-SP as shown 
in table 5. Women who had attained at least secondary education were 40% less likely to receive optimum doses 
of IPTp-SP (OR: 0.6; 95% CI: 0.4 – 0.9; p = 0.01). The likelihood of uptake of optimum IPTp-SP doses was 
significantly higher among women who stated that the nearest health facility opens every day (OR: 161.8; 95% 
CI: 29.5 – 885.7; p < 0.0001). Women who were given return dates were also 21 times more likely to receive the 
recommended doses of IPTp-SP (OR: 21.2; 95% CI: 7.9 – 56.5; p < 0.0001). Clients who reported that SP drugs 
are unsafe in pregnancy were 7 times more likely to take optimum doses of IPTp-SP as those who had indicated 
that they are safe. Those who believed that distance affected their clinic attendance were 80% less likely to receive 
optimum uptake of IPTp-SP doses (OR: 0.2; 95% CI: 0.06 – 08; p = 0.02). Being a protestant (p = 0.3), having 
had less than 4 previous pregnancies (p = 0.09) or deliveries (p = 0.7) and perception that IPTp-SP is recommended 
to be started after 1st trimester had no significant association with the outcome. 
Table 5: Multivariate logistic regression of predictors of the optimum uptake of IPTp-SP 
Risk factor Overall OR 95% CI Significance level 
(p value) 
Having attained at least secondary school education 0.6 0.4 – 0.9 0.01 
Protestant 1.2 0.8 – 1.9 0.3 
Less than 4 previous pregnancies 2.9 0.9 – 10.0 0.09 
Less than 4 previous deliveries 0.7 0.2 – 2.7 0.7 
Distance affects clinic attendance 0.2 0.06 – 0.8 0.02 
SP drugs are not safe during pregnancy 7.3 1.5 – 35.7 0.01 
IPTp-SP is recommended to be started after 1st trimester: 0.2 0.03 – 1.2 0.08 
Nearest health facility opens every day 161.8 29.5 – 885.7 < 0.0001 
Given return dates by the health provider during your visits 21.2 7.9 – 56.5 < 0.0001 
 
4.0 Discussion 
The objective of the study was to determine predictors of optimum uptake of IPTp-SP doses in Navakholo Sub-
County. Among the socio-demographic factors that were significantly associated with optimal uptake of IPTp-SP 
were socio-economic factors such as level of education, religion, past obstetric history and past delivery history.  
 
4.1 Client characteristics 
Although education plays a critical role in the transformation of behavior and may positively influence decision 
making, our study findings show the contrary. Findings in this study shows that, women who had attained 
secondary level of education and above were less likely to benefit from optimal uptake of IPTp-SP as opposed to 
their counterparts with less education although the association was borderline. The finding is supported by other 
study results (Mubyazi, et al., 2014; Rumisha, et al., 2014) which showed that women with higher level of 
education were less likely to take IPTp-SP. However, our results are in contrast to that of a study conducted in 
Uganda and Tanzania (Mpungu, et al., 2008; Exavery, et al., 2014) which revealed that women with higher level 
of education were more likely to take three or more doses of IPTp-SP. The decreased optimal uptake of IPTp-SP 
as evidenced in the current study could be attributed to such women’s busy schedules as in our study area (Olukaya, 
2013). Most of the times women with secondary level of education are usually in employment and perhaps, are 
unlikely to get time to regularly attend antenatal clinic which is usually open only during working days as they are 
usually a way on duty. 
In this survey, being a protestant was found to be significantly associated with optimal uptake of IPTp-SP as 
compared to other religions (Catholics and Muslims). In the recent past, there has been some disagreements in the 
Catholic leadership in Kenya and WHO regarding the safety of tetanus vaccine administration to pregnant women 
(Kenya Catholic Bishops press statement, 2015). There is a possibility that such church position regarding uptake 
of preventive medicine by pregnant mothers could have discouraged ANC clients who profess Catholic faith from 
taking optimal doses of IPTp-SP. 
Another notable finding from this study which is similar to a study that was done in Nigeria by Olukoya & 
Adebiyi (2013) was that women with 4 or less previous deliveries were more likely to take optimum doses of 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 
ISSN 2422-8419     An International Peer-reviewed Journal DOI: 10.7176/JHMN 
Vol.60, 2019 
 
94 
IPTp-SP (p = 0.02). Women who had had more than four deliveries and had not suffered malaria, may not consider 
the importance of malaria in pregnancy and thus would downplay the risk. Again, this group could be shying away 
from coming to hospital to avoid some of the questions asked at the facilities noting the number of children one 
has had as they do not want to be seen as having delivered so many children. On the contrary, comparing uptake 
of IPTp-SP with the number of children one had, a study conducted by Akinyele (2009) found that women who 
were carrying pregnancy for the 1st time, were found to be the highest consumers of IPTp-SP while the higher the 
number of children (four or more) the lower the uptake.  In a related study done in Cameroon, Ngimuh, et al., 
(2016) found that uptake of IPTp-SP was high in multiparous women. He associated this to the fact that multigravid 
(para 2+0 and above) women already knew the dangers of malaria in pregnancy since they had had a chance of 
receiving more health education on the importance of IPTp-SP and have complied hence increased its uptake. 
While this study agrees with studies done in Tanzania that women between the ages of 20-34 are the highest 
consumers of IPTp-SP (Kibusi, 2015; Amon, 2014), the results were not statistically significant. Being in this age 
group was not associated with optimal uptake of IPTp-SP doses (p = 0.7). Probably, at this age (20-34), most of 
the young women are getting into the stage of building their families through marriage and are eager to get healthy 
children from a malaria free antenatal period.  Ngimuh et al., (2016) did a similar study in Cameroon and in their 
findings, most IPTp-SP users were in the >25-year-old age group. This may be associated with the fact that women 
in this age group are mature and most of them have attained a higher level of education and understand the 
importance of health care which includes receiving IPTp-SP to protect themselves and their unborn babies.  
The findings in this study does not agree with the findings of Akinyele (2009), in which it was found that 
being married or staying with a partner, were associated with optimum uptake of IPTp-SP doses. This could be 
associated with the fact that couples tend to share views and encouragement. However, this study confirms the 
findings of Rumisha, et al., (2014) in which marital status was not a predictor of receiving more doses of IPTp-
SP. Sabin et al., (2010) also found insignificant association between marital status and uptake of optimum doses 
of IPTp-SP in Burkina Faso. 
 
4.2 Health Facility Related Factors that affect uptake of IPTp-SP 
Although in our study respondents were satisfied with the services offered, the findings from quantitative study 
did not find any association between issuance of ANC card and uptake of IPTp-SP. However, results from studies 
conducted in Mkuranga and Mufindi districts of Tanzania, Mubyazi, et al., (2014) found that pregnant women did 
not like the idea of sharing cups to swallow SP drugs in the clinic and that there was inadequate drinking water 
making them not attend ANC. This resulted in low uptake of IPTp-SP. In our study site, DOT policy is currently 
being implemented. The policy ensures that a pregnant woman takes SPs in the clinic under supervision. That 
notwithstanding, the approach seems to be forceful and disrespectful of the freedom of the clients as it does not 
allow them to opt out voluntarily. This may discourage pregnant women from attending ANC and eventually 
affecting uptake of IPTp-SP (Rumisha, et al., (2014).  
Availability of SP drugs is critical to improve uptake of IPTp-SP. Most of the respondents (99.5%) in this 
study reported that SP drugs were available as the drugs were supplied by a program supporting the Ministry of 
Health. Support from Health implementing partners in carrying out health care activities including procurement 
and distribution of SP drugs should be embraced as this ensures drug availability to increase uptake of IPTp-SP 
doses.  
 
4.3 Health Provider Related Factors that affect uptake of IPTp-SP 
This study found a significant association between ANC providers’ action of giving return dates and uptake of 
IPTp-SP doses. Those clients who reported to have been given return dates by the health care provider were 21 
times more likely to take optimal doses of IPTp-SP (OR 21.2, p = < 0.0001). This underscores the need to always 
remind clients that they need to come back for further assessments and care during pregnancy. This should be 
reinforced by noting return dates in their mother booklets for reference purpose and for easy remembrance.  
In a similar study conducted by Sabina et al., (2006), confusion on the side of health workers about timing 
and spacing of SP doses and restriction of SP in early pregnancy or difficulty in correctly assessing gestational age 
of the woman contributes to missed dosing of IPTp-SP. Hurley, et al., (2016) also found that poor patient 
counseling about IPTp-SP and especially when DOT is not consistently practiced may impact negatively on uptake 
of IPT-SP. This usually resulted from patient-provider interactions that were fairly brief. Women were often 
instructed to take the pills with little or no explanation about their purpose. 
Monitoring and supervision of ANC services ensures that lack of resources required for implementation of 
IPTp-SP program are promptly identified and addressed to ensure continuity of the program. This study found that 
there were no supervisory visits made to strengthen IPTp-SP program. Most of the staffs who were interviewed 
reported not having been visited. Lack of updates on IPTP-SP program hampered their service delivery. Indeed, 
supervision that targeted IPTp-SP services being offered was rarely done. Instead, County Health Management 
team who visited the facilities were interested in other services such as immunization, among others. The findings 
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in this study concur with a study done by Doku et al (2016) in Tamale Metropolis in Ghana, in which monitoring 
of IPTp-SP was poor and that staffs were unable to track their IPT coverage leading to low uptake of optimal doses 
of IPTp-SP. 
 
5.0 Conclusion 
In conclusion, this study confirms that uptake of optimal doses of IPTp-SP in Navakholo Sub-County is determined 
by giving clients return dates and opening of health facilities daily. Similarly, level of education, distance to health 
facility and the client’s perception on the safety of SP drugs in pregnancy are independently significantly 
associated with optimal uptake of IPTp-SP doses in the study area. Coverage rate of uptake of ≥ 3 doses of IPTp-
SP (50.1%) is still below the national recommendation of 80% with almost half of the pregnant women (49.9%) 
having taken only one to two doses and 7.7% failing to have taken any doses. The success of IPTp-SP program 
will contribute to reduction of maternal and neonatal mortalities arising from malaria infection in pregnancy.  
 
6.0 Recommendations 
 Community awareness through health education should target those women who have at least secondary 
level of education and above so as to increase awareness on the risks of malaria in pregnancy and safety 
of SPs in pregnancy. Community based promotional activities through CHVs should be strengthened to 
increase health seeking behaviour for the pregnant women to be able to utilize ANC services.  
 Health facilities should open on a daily basis and to run for 7 days a week so as to cater for the women 
who are employed and who may not get time during the weekdays to visit ANC.  
 Mobile clinics in areas that are hard to reach due to poor road network should be considered.  
 Ensure every client gets a return date. The county should employ more ANC health care workers so that 
staffs can have adequate time to engage their clients and provide full information including giving of 
return dates.  
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